Zantac Cancer Claim Information

ZANTAC CANCER CLAIM INFORMATION.

On September 13, 2019 the Food & Drug Administration (FDA) issued a public warning concerning Zantac and other similar ranitidine medicines (generics). The FDA reports that some ranitidine medicines, including some products commonly known as the brand-name drug Zantac®, contain a nitrosamine impurity called nitrosodimethylamine (NDMA).

NDMA (the contaminant identified in Zantac) is classified as a probable human carcinogen which means that it is more likely than not to cause cancer in humans. Recent studies have raised the specter of an association between NDMA and liver toxicity which can lead to the development of liver cancer and other related conditions brought about by an NDMA-induced “insult” to the liver.

Cancers that are linked to NDMA exposure include: Liver Cancer, Colorectal Cancer, Intestinal Cancer, Colon Cancer, Stomach Cancer and Kidney Cancer (Renal Cancer). Other possibly related cancers include: Lung Cancer, Pancreatic Cancer, Ovarian Cancer, Testicular Cancer and Esophageal Cancer. 

BRW Injury Lawyers are investigating these claims. If you or a loved one developed any of the above cancers after using Zantac (or other ranitidine medication) for a few months, you may have a claim. For more information call BRW Injury Lawyers at 251 433-7766 or email BRW: web_inquiry@brwlawyers.com    Please share this important information.

ZANTAC is a registered trademark of Warner-Lambert Company, used under license. In the United States, 75- and 150-mg tablets are available OTC. Zantac OTC is manufactured by Sanofi Consumer Healthcare.

REQUIRED DISCLAIMERS: Alabama Rule of Professional Conduct 7.2: No representation is made that the quality of legal service to be performed is greater than the services provided by other lawyers. The Mississippi Supreme Court advises that a decision on legal services is important and should not be based solely on advertisements. Free background information is available upon request to a Mississippi attorney. The listing of any area of practice by a Mississippi attorney does not indicate any certification of expertise therein. See Mississippi Rules of Professional Conduct Rule 7.2(d), Rule 7.4(a), Rule 7.6(a) (1997). Statement in compliance with Florida Bar Advertising Rules: “The hiring of a lawyer is an important decision that should not be based solely upon advertisements. Before you decide, ask us to send you free written information about our qualifications and experience. [Florida Rule 4-7.2(d)]. General Disclaimer: This information is posted for general information purposes to help those interested parties or persons with potential civil claims better understand their rights and potential causes of action. If readers are currently represented by an attorney on the subject matter of this post then they are encouraged to continue with said representation. No attorney-client relationship is established by this post.

Top Personal Injury Firm Opens Law Office in Foley, AL

One of Alabama’s most experienced auto-crash personal injury law firms has now opened an office in Foley, Alabama. The law firm of Boteler, Finley & Wolfe has been helping car crash victims with insurance claims for over 30 years. The senior partner in the firm, Mark Wolfe, has helped thousands of victims and their families recover compensation for their car crash injuries. In addition he has written numerous consumer publications for personal injury victims and he has taught CLE courses for attorneys on how to prepare and prosecute auto-crash injury claims. The attorneys at Boteler, Finley & Wolfe are all top-rated attorneys by peer review rating services such as AVVO.com.  They are the only dedicated injury law firm with an office in the Foley area. The new office address is 820 N. Alston Avenue, Suite B and free consultations are available by appointment only through the Mobile, AL office: 251 433-7766 or by rmail to Mark Wolfe, mark@bfw-lawyers.com